Clinical Trials

102 Articles

Chemistry tubes with purple, yellow and white liquids in a red rack
Research
July 31, 2020 • 3 Min

Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer

This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.

Dr. Zev Wainberg
Research
July 28, 2020 • 4 Min

NALIRIFOX Shows Promise in Early Studies

Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.

Image of a cancer drug target visualized at the atomic level
Research
July 7, 2020 • 2 Min

Slowing the Spread of Advanced Pancreatic Cancer

Researchers are testing a kinase inhibitor that is used to treat lung diseases, including a type of lung cancer, against pancreatic cancer.

Dr. Daniel Holzwanger
Research
June 19, 2020 • 5 Min

DIRECT Study Focuses on NanoKnife Technology

Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.

red tops and black tops of new beakers against a silver background
Research
June 11, 2020 • 3 Min

Chemotherapy Plus Minimally Invasive Surgery for Pancreatic Cancer

Researchers want to know if irreversible electroporation (IRE) makes it easier for chemotherapy to reach pancreatic cancer cells.

Fractal flame ribbons in whte and red on a black background
Research
May 15, 2020 • 2 Min

Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer

Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.

Test tubes in a gold test tube holder
Research
April 21, 2020 • 2 Min

Testing a Drug that Works Only in the Tumor Microenvironment

Scientists are trying a new type of drug combination that gets activated only in the unique conditions of the tumor microenvironment.

The tops of closed lab vials as seen from overhead against a blue-ish background
Research
March 26, 2020 • 2 Min

Combining Two Drugs with Different Approaches to Enhance Treatment

A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.

Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos
Research
March 23, 2020 • 6 Min

Challenge Grant Recipients Moving Forward

The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.

Dr. Andrew Coveler
Research
March 10, 2020 • 5 Min

Inhibiting Cell Division With Alternating Electric Fields

Dr. Andrew Coveler explains how electric fields are being used to disrupt pancreatic cancer cell division, to make tumors more removable.

Researcher Ken Olive
Research
February 13, 2020 • 5 Min

Clinical Trial For OncoTreat Being Developed

Medical research falls into one of three buckets: basic, clinical, and translational. Basic research is all about the nuts and bolts, demystifying at a fundamental level what makes a lethal disease like pancreatic cancer tick. Clinical research is all about patients, and finding out through rigorously controlled trials whether certain new drugs or other approaches […]

water droplets and threads of mold against a green-yellow-pink background
Research
February 5, 2020 • 2 Min

Testing Techniques to Remove Stray Pancreatic Cancer Cells After Surgery

Researchers are studying whether peritoneal washing after pancreatic cancer surgery decreases recurrence of the cancer by removing stray cancer cells.

purple hands
Research
January 23, 2020 • 7 Min

What Happens When Pancreatic Cancer Clinical Trials Fail?

Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.

DNA helix made of metal, plastic and stained glass
Research
January 10, 2020 • 2 Min

Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers

Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.

Test tubes with blue and yellow liquids in them
Research
December 13, 2019 • 3 Min

Testing Treatment Combinations to Make Surgery More Effective

Can losartan (a high blood pressure drug) and immunotherapy combined with standard chemotherapy and radiation be an effective combination against pancreatic cancer?